Go Pro

Iovance Biotherapeutics (IOVA) Institutional Ownership

Iovance Biotherapeutics logo
$4.31 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$4.27 -0.04 (-0.90%)
As of 07/2/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Iovance Biotherapeutics (NASDAQ:IOVA)

Current
Institutional Ownership
Percentage
77.03%
Number of
Institutional Buyers
(last 12 months)
149
Total
Institutional Inflows
(last 12 months)
$132.81M
Number of
Institutional Sellers
(last 12 months)
65
Total
Institutional Outflows
(last 12 months)
$77.94M
Get IOVA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Iovance Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

IOVA Institutional Buying and Selling by Quarter

Iovance Biotherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/2/2026Optiver Holding B.V.36,660$129K0.0%+24.0%0.008%
5/19/2026Bank of America Corp DE8,490,119$29.80M0.0%-40.5%1.901%
5/19/2026Janus Henderson Group PLC141,672$498K0.0%+55.1%0.032%
5/19/2026Arkadios Wealth Advisors20,262$71K0.0%N/A0.005%
5/18/2026Royal Bank of Canada625,035$2.19M0.0%+2.7%0.140%
5/16/2026The Manufacturers Life Insurance Company 365,471$1.28M0.0%+57.9%0.082%
5/15/2026Corsair Capital Management L.P.350,000$1.23M0.2%+16.7%0.078%
5/15/2026Rice Hall James & Associates LLC1,514,907$5.32M0.3%+6.3%0.339%
5/14/2026Knott David M Jr1,600,000$5.62M3.3%N/A0.358%
5/14/2026Sei Investments Co.122,180$429K0.0%+15.7%0.027%
5/13/2026Cetera Investment Advisers31,094$109K0.0%-56.0%0.007%
5/8/2026PNC Financial Services Group Inc.25,052$88K0.0%-50.7%0.006%
5/7/2026Dimensional Fund Advisors LP2,645,702$9.28M0.0%+71.9%0.593%
5/7/2026KBC Group NV9,586$34K0.0%N/A0.002%
5/6/2026Annis Gardner Whiting Capital Advisors LLC100,400$352K0.1%N/A0.022%
5/6/2026Ceera Investments LLC12,465$44K0.0%N/A0.003%
5/5/2026Sanctuary Advisors LLC10,968$38K0.0%N/A0.002%
5/4/2026Chicago Partners Investment Group LLC52,653$186K0.0%+29.7%0.012%
5/1/2026Fifth Third Bancorp11,230$39K0.0%N/A0.003%
5/1/2026Sequoia Financial Advisors LLC31,266$110K0.0%N/A0.007%
4/30/2026Hsbc Holdings PLC27,484$98K0.0%-84.8%0.006%
4/30/2026Kestra Advisory Services LLC34,891$122K0.0%+242.4%0.008%
4/30/2026Granite Investment Partners LLC18,843$66K0.0%+77.1%0.005%
4/29/2026R Squared Ltd26,883$94K0.1%-22.2%0.007%
4/28/2026Abel Hall LLC24,406$86K0.0%N/A0.006%
4/27/2026Leonteq Securities AG160,000$562K0.0%-17.9%0.039%
4/22/2026Pictet Asset Management Holding SA43,048$151K0.0%+58.7%0.010%
4/22/2026Sterling Capital Management LLC11,177$39K0.0%-36.9%0.003%
4/21/2026Sugar Maple Asset Management LLC120,000$421K0.3%+9.1%0.029%
4/21/2026Penbrook Management LLC42,445$149K0.1%+25.0%0.010%
4/17/2026Krilogy Financial LLC15,376$58K0.0%N/A0.004%
4/16/2026SG Americas Securities LLC167,878$589K0.0%+203.1%0.041%
3/20/2026Hsbc Holdings PLC180,541$497K0.0%+651.5%0.044%
3/17/2026Rockefeller Capital Management L.P.50,726$138K0.0%+187.6%0.012%
3/3/2026Caitong International Asset Management Co. Ltd47,277$129K0.0%+658.9%0.011%
2/19/2026Invesco Ltd.1,251,665$3.42M0.0%+32.4%0.315%
2/18/2026XTX Topco Ltd522,934$1.43M0.0%+148.4%0.132%
2/18/2026VARCOV Co.92,806$253K0.1%N/A0.023%
2/18/2026Virtus Investment Advisers LLC310,641$848K0.2%+61.5%0.078%
2/18/2026Tudor Investment Corp ET AL179,494$490K0.0%+47.4%0.045%
SPCX Warning - and Worst News for Stocks in 50 Years (Ad)

Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in 50 years - and it has nothing to do with a single stock. According to multiple Wall Street banks, a coming crisis could keep your portfolio in the red for 10 years or longer. Keith Kaplan, CEO of TradeSmith, is sharing what you can do to protect your wealth before it hits.tc pixel

Learn how to prepare your portfolio for what's coming next
2/18/2026Quadrature Capital Ltd318,703$870K0.0%N/A0.080%
2/18/2026One68 Global Capital LLC20,000$55K0.6%N/A0.005%
2/18/2026Perceptive Advisors LLC152,714$417K0.0%N/A0.038%
2/18/2026Intrepid Family Office LLC30,000$82K0.1%-25.0%0.008%
2/18/2026Invenomic Capital Management LP11,959,505$32.65M1.5%+13.5%3.013%
2/18/2026Engineers Gate Manager LP194,691$532K0.0%N/A0.049%
2/18/2026First Manhattan CO. LLC.28,998$79K0.0%-46.6%0.007%
2/18/2026Balyasny Asset Management L.P.68,038$186K0.0%-24.9%0.017%
2/17/2026AQR Capital Management LLC110,591$302K0.0%+9.1%0.028%
2/17/2026Cetera Investment Advisers70,674$193K0.0%-7.0%0.018%
2/17/2026EFG International AG168,000$459K0.0%N/A0.042%
2/17/2026Jain Global LLC312,096$852K0.0%N/A0.079%
2/17/2026Jump Financial LLC22,062$60K0.0%N/A0.006%
2/17/2026Price T Rowe Associates Inc. MD1,191,828$3.26M0.0%-42.1%0.300%
2/17/2026Osaic Holdings Inc.102,155$279K0.0%-4.0%0.026%
2/17/2026Quantitative Investment Management LLC138,583$378K0.0%N/A0.035%
2/17/2026Corsair Capital Management L.P.300,000$819K0.1%N/A0.076%
2/17/2026California State Teachers Retirement System295,997$808K0.0%+18.0%0.075%
2/17/2026Russell Investments Group Ltd.198,043$541K0.0%+195.7%0.050%
2/17/2026State of Wisconsin Investment Board109,997$300K0.0%-4.4%0.028%
2/17/2026Captrust Financial Advisors46,812$128K0.0%+13.5%0.012%
2/17/2026ExodusPoint Capital Management LP281,477$768K0.0%+568.2%0.071%
2/17/2026Royal Bank of Canada608,459$1.66M0.0%-60.9%0.153%
2/17/2026Beacon Financial Advisory LLC16,195$44K0.0%-20.0%0.004%
2/17/2026Rice Hall James & Associates LLC1,425,088$3.89M0.2%-1.8%0.359%
2/17/2026Gould Asset Management LLC CA31,735$87K0.0%+170.4%0.008%
2/16/2026Squarepoint Ops LLC25,001$68K0.0%-42.9%0.006%
2/16/2026WealthTrust Axiom LLC65,000$177K0.0%+62.5%0.016%
2/16/2026MML Investors Services LLC111,848$305K0.0%N/A0.028%
2/16/2026Healthcare of Ontario Pension Plan Trust Fund628,537$1.72M0.0%+379.8%0.158%
2/16/2026Destination Wealth Management20,000$55K0.0%N/A0.005%
2/16/2026Barclays PLC1,127,157$3.08M0.0%+20.3%0.284%
2/13/2026Arete Wealth Advisors LLC18,700$51K0.0%-22.9%0.005%
2/13/2026The Manufacturers Life Insurance Company 231,443$637K0.0%+2.8%0.058%
2/13/2026Quinn Opportunity Partners LLC95,000$259K0.0%-40.6%0.024%
2/13/2026CANADA LIFE ASSURANCE Co40,958$112K0.0%+20.4%0.010%
2/13/2026Stifel Financial Corp329,815$900K0.0%-5.7%0.083%
2/13/2026Rafferty Asset Management LLC706,450$1.93M0.0%+46.3%0.178%
2/13/2026Headlands Technologies LLC70,662$193K0.0%N/A0.018%
2/13/2026Charles Schwab Investment Management Inc.2,753,343$7.52M0.0%+9.9%0.694%
2/13/2026State Street Corp20,161,445$55.04M0.0%+51.5%5.079%
2/13/2026Dynamic Technology Lab Private Ltd16,872$46K0.0%N/A0.004%
2/13/2026Caitong International Asset Management Co. Ltd33,737$92K0.3%+441.5%0.008%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC469,706$1.28M0.0%-2.5%0.118%
2/13/2026Wells Fargo & Company MN1,993,337$5.44M0.0%+31.4%0.502%
2/13/2026Rhenman & Partners Asset Management AB1,595,327$4.36M0.4%+45.3%0.402%
2/12/2026HRT Financial LP4,356,010$11.89M0.0%+1,078.3%1.097%
2/12/2026DRW Securities LLC28,558$78K0.0%N/A0.007%
2/12/2026MetLife Investment Management LLC170,782$466K0.0%+20.5%0.043%
2/12/2026Cibc World Markets Corp20,344$56K0.0%N/A0.005%
Iran War Shock: What I Was Told In That Private Meeting (Ad)

You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.tc pixel

2/12/2026Renaissance Technologies LLC651,000$1.78M0.0%N/A0.164%
2/12/2026Dimensional Fund Advisors LP1,539,110$4.20M0.0%-45.5%0.388%
2/12/2026Federated Hermes Inc.9,551$26K0.0%-36.8%0.002%
2/12/2026Granite Investment Partners LLC10,638$29K0.0%N/A0.003%
2/12/2026Swiss National Bank606,456$1.66M0.0%+17.1%0.153%
2/12/2026Nuveen LLC1,385,988$3.78M0.0%+10.7%0.349%
2/12/2026Xponance LLC24,288$66K0.0%+19.4%0.006%
2/11/2026Deutsche Bank AG690,416$1.89M0.0%+7.0%0.174%
2/11/2026Motley Fool Asset Management LLC10,760$29K0.0%N/A0.003%
2/11/2026Orion Investment Co1,856,934$5.07M1.6%+0.3%0.468%


IOVA Institutional Ownership - Frequently Asked Questions

During the previous two years, 293 institutional investors and hedge funds held shares of Iovance Biotherapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($74.28M), Hood River Capital Management LLC ($66.54M), State Street Corp ($55.04M), Artisan Partners Limited Partnership ($33.61M), Invenomic Capital Management LP ($32.65M), Bank of America Corp DE ($29.80M), and Avoro Capital Advisors LLC ($25.90M).Learn more on Iovance Biotherapeutics' institutional investors.

77.03% of Iovance Biotherapeutics' stock is owned by institutional investors. Learn more on IOVA's institutional investor holdings.

Of the 257 institutional investors that purchased Iovance Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Invenomic Capital Management LP ($9.15M), Long Focus Capital Management LLC ($7.45M), State Street Corp ($7.43M), Perceptive Advisors LLC ($6.81M), Principal Financial Group Inc. ($4.57M), Palo Alto Investors LP ($4.36M), and HRT Financial LP ($3.99M).

Institutional investors have bought a total of 53,425,324 shares in the last 24 months. This purchase volume represents approximately $132.81M in transactions.

Of the 65 institutional investors that sold Iovance Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Bank of America Corp DE ($5.79M), Millennium Management LLC ($4.92M), Soleus Capital Management L.P. ($4.52M), Long Focus Capital Management LLC ($2.70M), Two Sigma Investments LP ($1.89M), Principal Financial Group Inc. ($1.59M), and Dimensional Fund Advisors LP ($1.39M).

Institutional investors have sold a total of 32,526,184 shares in the last 24 months. This volume of shares sold represents approximately $77.94M in transactions.



This page (NASDAQ:IOVA) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners